Posted by Bob on October 22, 2013, at 21:21:31
In reply to Re: Cariprazine - A better Abilify?, posted by SLS on October 22, 2013, at 5:39:56
> Do you think that the D3 receptor in the nucleus accumbens makes a good target in treating schizophrenia? Negative symptoms only? It is important to recognize that D2 receptors in the striatum will still be antagonized. I don't know what the D3/D2 ratio in binding affinity is for cariprazine.
>
> http://www.ncbi.nlm.nih.gov/pubmed/9473144
>
> http://en.wikipedia.org/wiki/Cariprazine
>
> http://www.ncbi.nlm.nih.gov/pubmed/?term=cariprazine+striatum
>
>
> - ScottScott,
Did you notice that the Wiki entry you gave the link for said that one of the most common side effects was weight gain?
Bob
poster:Bob
thread:1052699
URL: http://www.dr-bob.org/babble/20130930/msgs/1052821.html